Latin American School of Oncology (ELO)

964 posts

Latin American School of Oncology (ELO) banner
Latin American School of Oncology (ELO)

Latin American School of Oncology (ELO)

@school_latin

ELO promotes education and research to eradicate cancer in Latin America

Katılım Mayıs 2019
1.1K Takip Edilen1.5K Takipçiler
Latin American School of Oncology (ELO) retweetledi
ALFONSO DUEÑAS GONZALEZ
ALFONSO DUEÑAS GONZALEZ@duenas_gon28·
qeios.com/read/RNYMQG THE DEVIL LIES IN THE DETAILS: AN ANALYSIS OF SIX ONCOLOGY RANDOMISED CONTROLLED TRIALS Abstract Randomized Controlled Trials (RCTs) in oncology are the backbone of advancing the clinical practice of oncology. Their significance is particularly pronounced in high-impact and influential journals such as the NEJM, The Lancet, The Lancet Oncol, JAMA, JAMA Oncol, and JCO. However, previous works have highlighted that RCTs often fail to provide complete reporting of survival endpoints, which can jeopardize the oncologist's interpretation of the study findings.This is a narrative review in which we provide some basic concepts of survival statistics and apply these in the analysis of six RCTs published in these six journals. These articles were selected solely by scanning the latest issues (printed) on the journals' web pages. The first RCT on a solid tumor to appear in the corresponding journals was selected. No other criteria were applied.We found that these six trials failed to provide crucial data, such as the number of survival events, patient censoring, and the presentation of both absolute and relative effect sizes on survival, to different extents.This report study focuses solely on a small subset of RCTs from high-impact journals, which may not represent the reporting practices of oncology RCTs published in other journals or at different times. The most well-informed party should be the patients, who ultimately benefit from improved RCT reporting. We hope this work will inspire oncologists to sharpen their skills in analyzing RCTs and encourage statistician experts to contribute their valuable insights and knowledge on this issue.
English
0
4
4
2.8K
Latin American School of Oncology (ELO) retweetledi
Suyapa Bejarano
Suyapa Bejarano@SuyapaSube·
pubmed.ncbi.nlm.nih.gov/39159409/ Community Led Actions in Oncology. Read the Innovations by LA radiooncologsits to cope with COVID-19. Your comments will be welcome. 🧐☢️
English
0
5
7
436
Latin American School of Oncology (ELO) retweetledi
Ivy Riano, M.D.
Ivy Riano, M.D.@IvyLorena_Md·
PUBLISHED: Our NIH-funded CLARO PARTE study for Latin America and the Caribbean Countries suggests scalable practices in #radiationoncology clinics to guide actions during future large-scale public health crises in low- and middle-income countries 👉🏼 ascopubs.org/doi/10.1200/GO…
Ivy Riano, M.D. tweet media
English
4
16
77
9.7K
Latin American School of Oncology (ELO) retweetledi
ecancer
ecancer@ecancer·
Latin American Cancer Week, #Selac May 13-17, 2024, will provide a 360° picture of the impact of the growing global incidence of #cancer, the challenges it presents for the implementation of strategies for its control. @OrgSlacom selac.org
ecancer tweet media
English
0
4
3
931
Latin American School of Oncology (ELO) retweetledi
INSP México
INSP México@inspmx·
Para preparar un litro de refresco se utilizan más de 200 litros de agua. Dejar de consumir refrescos es cuidar el agua. #Agua #Refresco
INSP México tweet media
Español
6
142
301
14.9K